Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.yebeh.2021.108550 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Comparison of plasma concentration and sedative effect of sublingual and intranasal dexmedetomidine in children: A double-blind randomised controlled study.
Acta Anaesthesiol Scand
March 2025
Department of Anaesthesiology, Pain Medicine and Critical Care, All India Institute of Medical Sciences, New Delhi, Delhi, India.
Background: Pharmacokinetics and sedative effects of sublingual dexmedetomidine have not been established in children. The primary aim was to compare peak plasma concentration, time to reach peak plasma concentration and area under the curve with 2 μg/kg sublingual and intranasal dexmedetomidine. The secondary aims were to compare the depth of sedation, parental separation anxiety, mask acceptance, heart rate changes, analgesic requirements and recovery time with 2 μg/kg sublingual and intranasal dexmedetomidine in children.
View Article and Find Full Text PDFCan Intranasal Naloxone Prevent Hypoglycemia-Associated Autonomic Failure?
J Clin Endocrinol Metab
September 2024
Research Division, Joslin Diabetes Center, Boston MA.
Comment on intranasal esketamine combined with oral midazolam provides adequate sedation for outpatient pediatric dental procedures.
Int J Surg
September 2024
Department Orthodontics, Guiyang Hospital of Stomatology.
In Response to "Comment on Ensuring the Efficacy and Safety of Approved Medications".
J Med Toxicol
July 2024
Department of Emergency Medicine, Rutgers New Jersey Medical School, Newark, NJ, USA.
Comment on "Ensuring the Efficacy and Safety of Approved Medications ".
J Med Toxicol
July 2024
ARS Pharmaceuticals, Inc., 11682 El Camino Real, Suite 120, 92130, San Diego, California, USA.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!